In mice, researchers have discovered the presence of oncostreams, highly active cells connected to how brain tumors grow and invade healthy tissue.

Men with advanced prostate cancer taking abiraterone or enzalutamide plus hormone therapy were at higher risk of serious medical issues than their peers undergoing hormone therapy alone.

Known as histotripsy, the device not only kills cancer cells but also stimulates the immune system as an added defense.

By raising awareness about the correlation between increased radiation exposure and cardiac events, average doses were reduced without minimizing cancer treatment. 

Unequal outcomes, and higher spending, seen in patients over 65 who are “dual eligible” for Medicare and Medicaid.

A survey of young adult cancer survivors illustrates the compromises people make when asking family, friends for financial support during cancer treatment.